Chalcone based aryloxypropanolamines as potential antihyperglycemic agents
- 27 October 2006
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (3), 799-802
- https://doi.org/10.1016/j.bmcl.2006.10.068
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Synthesis and antihyperglycemic activity of chalcone based aryloxypropanolaminesBioorganic & Medicinal Chemistry, 2004
- Novel strategies for the pharmacological management of type 2 diabetesTrends in Pharmacological Sciences, 2004
- Design, Synthesis, and Evaluation of Novel Boronic-Chalcone Derivatives as Antitumor AgentsJournal of Medicinal Chemistry, 2003
- Surgical implantation of adipose tissue reverses diabetes in lipoatrophic miceJCI Insight, 2000
- Antileishmanial Chalcones: Statistical Design, Synthesis, and Three-Dimensional Quantitative Structure−Activity Relationship AnalysisJournal of Medicinal Chemistry, 1998
- Synthesis and Anti-inflammatory Effect of Chalcones and Related CompoundsPharmaceutical Research, 1998
- The Novel Oxygenated Chalcone, 2,4‐Dimethoxy‐4'‐Butoxychalcone, Exhibits Potent Activity against Human Malaria ParasitePlasmodium falciparumIn Vitro and Rodent ParasitesPlasmodium bergheiandPlasmodium yoeliiIn VivoThe Journal of Infectious Diseases, 1997
- Antioxidant Constituents from Licorice Roots: Isolation, Structure Elucidation and Antioxidative Capacity Toward LDL OxidationFree Radical Biology & Medicine, 1997
- 3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitorsJournal of Medicinal Chemistry, 1993
- Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent .beta.-adrenergic agonist virtually specific for .beta.3 receptors. A promising antidiabetic and antiobesity agentJournal of Medicinal Chemistry, 1992